CDH Venture Management III Company Limited

CDH Venture Management III Company Limited is a dedicated venture capital management entity under the CDH Investments umbrella — one of China's oldest and largest homegrown alternative asset managers, established in 2002. The venture arm operates alongside CDH's private equity, mezzanine credit, real estate, and public securities platforms. While sharing the CDH brand and certain back-office infrastructure, the venture team maintains separate fund vintages, distinct investment committees, and a dedicated mandate focused on growth-stage technology and healthcare investments.

CDH Venture concentrates on growth equity and late-stage venture opportunities, writing initial checks that range from approximately $5 million to over $100 million. The firm prefers companies with established revenue traction and clear pathways to public-market liquidity or strategic exit. While occasionally participating in earlier-stage rounds alongside co-investors, the core mandate avoids seed-stage and pre-revenue risk profiles.

The venture arm maintains active exposure to enterprise technology, healthcare — including AI-enabled drug discovery through positions like XtalPi — consumer technology, and financial services. Sectors explicitly outside the mandate include heavy industrial manufacturing, traditional energy extraction, and real estate development, which are covered by CDH's separate buyout and credit platforms.

CDH Venture benefits from the parent firm's two-decade track record in Chinese private equity, which has produced deep relationships with industrial conglomerates, state-owned enterprise executives, and serial entrepreneurs who graduated from CDH's buyout portfolio companies. These networks generate proprietary referrals that standalone venture firms without a buyout heritage rarely access, particularly in enterprise services and advanced manufacturing adjacencies.